| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.906 | 30.976 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 34.386 | 42.069 | 110.234 | 42.099 | 15.000 | 6.256 | 289.995 | 26.730 | 248.631 | 110.594 |
| Total Expenses - EUR | 41.675 | 43.243 | 115.379 | 53.465 | 22.728 | 12.804 | 179.163 | 25.077 | 251.865 | 113.520 |
| Gross Profit/Loss - EUR | -7.289 | -1.174 | -5.145 | -11.366 | -7.729 | -6.549 | 110.831 | 1.652 | -3.234 | -2.925 |
| Net Profit/Loss - EUR | -8.306 | -2.218 | -5.221 | -11.366 | -7.729 | -6.673 | 108.555 | 1.487 | -3.234 | -2.925 |
| Employees | 3 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Mârza Medoptic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.019 | 36.325 | 14.076 | 10.567 | 7.174 | 0 | 0 | 1.522 | 817 | 116 |
| Current Assets | 10.557 | 888 | 118.982 | 164.315 | 176.245 | 171.885 | 275.817 | 277.238 | 328.786 | 455.067 |
| Inventories | 7.258 | 282 | 107.940 | 159.869 | 173.349 | 171.492 | 55.024 | 75.440 | 322.500 | 440.155 |
| Receivables | 3.015 | 591 | 10.597 | 3.754 | 1.839 | 318 | 2.048 | 1.449 | 5.995 | 9.072 |
| Cash | 283 | 15 | 444 | 692 | 1.057 | 75 | 218.745 | 200.349 | 291 | 5.840 |
| Shareholders Funds | -31.154 | -33.054 | -37.716 | -48.390 | -55.181 | -60.808 | 49.096 | 50.735 | 47.348 | 44.158 |
| Social Capital | 2.250 | 2.227 | 2.189 | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | 55.729 | 70.267 | 170.774 | 223.340 | 238.600 | 232.693 | 226.722 | 228.024 | 282.256 | 411.025 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4110 - 4110" | |||||||||
| CAEN Financial Year |
4110
|
|||||||||
Comments - Mârza Medoptic Srl